SURUSS aims to identify the most effective, safe and cost-effective method of antenatal screening for Down’s syndrome using nuchal translucency (NT), maternal serum and urine markers in the first and second trimesters of pregnancy, and maternal age in various combinations.
References
Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM.
First and second trimester antenatal screening for Down's syndrome: the
results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health
Technol Assess 2003; 7 (11)
Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM.
First and Second trimester Antenatal screening for Down’s syndrome: the
results of the Serum, Urine and Ultrasound Screening Study (SURUSS).
J Med Screen 2003; 10: 56-105.
Online
Please click here for our SURUSS links page with links to online versions of the report.
Responses
Please click here for the SURUSS Research Group's responses to comments on SURUSS.
Screening costs
Please click here for our Screening Cost Calculator. This allows you to calculate of the cost of antenatal screening for Downs Syndrome based on the results of SURUSS (amended in the light of the revised estimates of screening performance published in Prenatal Diagnosis [2004]). You may customise the result by changing currencies and inserting your own costs and rates.